Institut Catalá d'Oncologia (ICO Girona). Hospital Dr. Josep Trueta

Girona 17007

0 studies enrolling now · 1 studies all time

What they study most

Pancreatic Cancer Non-resectable

Studies at this site

• Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer — Completed